Interleukin-1 receptor antagonist production during infectious and noninfectious systemic inflammatory response syndrome

Critical Care Medicine

Volumn 28, Issue 7, 2000, Pages 2277-2282

  Marie, Christelle ^a   Cavaillon, Jean Marc ^a   Fitting, Catherine ^a   Muret, Jane ^a   Payen, Didier ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cardiopulmonary bypass; Cytokines; Inflammation; Interleukin 8; Neutrophils; Plasma; Sepsis; Surgery

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; MALE; NEUTROPHIL; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0033864325     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200007000-00016     Document Type: Article

References (38)

1. 1. Fischer E, Marano MA, Van Zee KJ, et al: Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 1992; 89:1551-1557
2. 2. Rogy MA, Coyle SM, Oldenburg HS, et al: Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg 1994; 178:132-138
3. 3. Gardlund B, Sjölin J, Nilsson A, et al: Plasma levels of cytokines in primary septic shock in humans: Correlation with disease severity. J Infect Dis 1995; 172:296-301
4. 4. Mandrup-Poulsen T, Wogensen LD, Jensen M, et al: Circulating IL-1ra concentrations are increased in adult patients with thermal injury. Crit Care Med 1995; 23:26-33
5. 5. McBride WT, Armstrong MA, Crockard AD, et al: Cytokine balance and immunosuppressive changes at cardiac surgery: Contrasting response between patients and isolated CPB circuits. Br J Anaesth 1995; 75:724-733
6. 6. Van Deuren M, Van Der Ven-Jongekrijg H, Vannier E, et al: The pattern of IL-1β and its modulating agents IL-1ra and sIL-1R type II in acute meningococcal infection. Blood 1997; 90:1101-1108
7. 7. Samson LM, Allen UD, Creery WD, et al: Elevated IL-1ra levels in pediatric sepsis syndrome. J Pediatr 1997; 131:587-591
8. 8. Kawamura T, Wakusawa R, Inada K: Interleukin-10 and interleukin-1 receptor antagonists increase during cardiac surgery. Can J Anaesth 1997; 44:38-42
9. 9. Dekleijn E, Drenth J, Pesman GJ, et al: Circulating and ex vivo production of pyrogenic cytokines and interleukin-1 receptor antagonist in 123 patients with fever of unknown origin. J Infect Dis 1997; 175:191-195
10. 10. Küster H, Weiss M, Willeitner AE, et al: Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 1998; 352:1271-1277
11. 11. Chapiro J, Maillet F, Charpentier A, et al: Stimulation of cytokine production by grampositive bacteria in a neutropenic patient: Difficulty of establishing a cytokine profile-bacterial family relationship. Br J Haematol 1996; 95:435-436
12. 12. Luger A, Graf H, Schwarz HP, et al: Decreased serum interleukin-1 activity and monocytes interleukin-1 production in patients with fatal sepsis. Crit Care Med 1986; 14:458-461
13. 13. Muñoz C, Carlet J, Fitting C, et al: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88:1747-1754
14. 14. Wood J, Rodrick M, O'Mahony J, et al: Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann Surg 1984; 200: 311-320
15. 15. Ertel W, Keel M, Neidhardt R, et al: Inhibition of the defense system stimulating interleukin-12 interferon-α pathway during critical illness. Blood 1997; 89:1612-1620
16. 16. McCall CE, Grosso-Wilmoth LM, LaRue K, et al: Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1993; 91:853-861
17. 17. Marie C, Muret J, Fitting C, et al: Reduced ex vivo interleukin-8 production by neutrophils in septic and non-septic systemic inflammatory response syndrome. Blood 1998; 91: 3439-3446
18. 18. Marchant A, Alegre M, Hakim A, et al: Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995; 15:265-272
19. 19. Ertel W, Kremer J, Kenney J, et al: Down-regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995; 85:1341-1347
20. 20. van Deuren M, Van Der Ven-Jongekrijg H, Demacker PNM, et al: Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 1994; 169:157-161
21. 21. Butcher C, Steinkasserer A, Tejura S, et al: Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist. J Immunol 1994; 153: 701-711
22. 22. Muzio M, Polentarutti N, Sironi M, et al: Cloning and characterization of a new isoform of the interleukin-1 receptor antagonist. J Exp Med 1995; 182:623-628
23. 23. Grzelak I, Olszewski WL, Rowinski W: Blood mononuclear cell production of IL-1 and IL-2 following moderate surgical trauma. Eur Surg Res 1989; 21:114-122
24. 24. Cabié A, Fitting C, Farkas J-C, et al: Influence of surgery on in-vitro cytokine production by human monocytes. Cytokine 1992; 4:576-580
25. 25. Jahns G, Haeffner-Cavaillon N, Nydegger UE, et al: Complement activation and cytokine production as consequences of immunological bioincompatibility of extracorporeal circuits. Clin Mater 1993; 14:303-336
26. 26. Bone RC, Fisher CJ, Clemmer TP, et al: Sepsis syndrome: A valid clinical entity. Crit Care Med 1989; 17:389-393
27. 27. Marie C, Fitting C. Cheval C, et al: Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome. Infect Immun 1997; 65:865-871
28. 28. Cavaillon JM, Muñoz C, Fitting C, et al: Circulating cytokines: The tip of the iceberg? Circ Shock 1992; 38:145-152
29. 29. Fischer E, Van Zee KJ, Marano MA, et al: Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 1992; 79:2196-2200
30. 30. Marie C, Pitton C, Fitting C, et al: IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra by human neutrophils. Cytokine 1996; 8:147-151
31. 31. Gasperini S, Zambello R, Agostini C, et al: Impaired cytokine production by neutrophils isolated from patients with AIDS. AIDS 1998; 12:373-379
32. 32. Marie C, Pitton C, Fitting C, et al: Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGFβ) of interleukin-8 production by LPS-and/or TNFα-activated human polymorphonuclear cells. Mediators Inflamm 1996; 5:334-340
33. 33. Joyce DA, Steer JH, Kloda A: Dexamethasone antagonizes IL-4 and IL-10-induced release of IL-1ra by monocytes but augments IL-4-, IL-10-, and TGF-beta-induced suppression of TNF-alpha release. J Interferon Cytokine Res 1996; 16:511-517
34. 34. Sauer J, Castren M, Hopfner U, et al: Inhibition of LPS-induced IL-1ra synthesis by cortisol. Involvement of the mineralocorticoid receptor. J Clin Endocrinol Metab 1996; 81: 73-79
35. 35. Levine SJ, Benfield T, Shelhamer JH: Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line. Am J Respir Cell Mol Biol 1996; 15:245-251
36. 36. Malyak M, Guthridge JM, Hance KR, et al: Characterization of a low molecular weight isoform of IL-1 receptor antagonist. J Immunol 1998; 161:1997-2003
37. 37. Bone RC, Grodzin CJ, Balk RA. Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997; 121:235-243
38. 38. Gabay C, Smith MF, Eidlen D, et al: Interleukin-1 receptor antagonist is an acute phase protein. J Clin Invest 1997; 99: 2930-2940